Hackers have already demanded ransom for removing sensitive patient data. Could your product foil future attacks?
News & Features
Iota Biosciences has raised about $15 million in a series A round to help further develop its millimeter-sized neural dust platform.
The company has had significant struggles with the EndoBarrier in the past, but a nod from FDA and the IRB to begin a new pivotal trial might be step back in the right direction for the technology.
The definition of a biomaterial has evolved over time, but given today's efforts to better characterize medical device biocompatibility, is a catch-all term for some materials misleading?
NuVasive has been in the news this week after it was reported that Smith & Nephew was interested in acquiring the company for more than $3 billion. Neither company has officially commented on the rumored deal.
We’ve offered a few predictions on what medtech developments could unfold this year. But what about the concerns that could preoccupy medtech professionals?
In addition to J&J picking up Auris Health for $3.4 billion, Roger Smith, Phd, who follows the surgical robotics market closely, said we could continue to see large medtech companies making acquisitions in the space.
University of Wisconsin School of Medicine and Public Health Researchers are using positron emission tomography with 18F-fluorofuranylnorprogesterone to give better insight on hormonal therapies for the treatment of breast cancer.
The AdVance XP Male Sling System has been redesigned for ease of placement and improved stability, the company noted.
What should medical device companies be doing to mitigate cybersecurity risks? One expert shared his insight on the subject during MD&M West 2019.
The two companies worked together to develop a smart cable and software module, which would enable compatibility between the FORE-SIGHT sensor and the HemoSphere platform.
3D printing is once again a hot topic in the world of medical device manufacturers, but is it more than just hype this time?